A Focus on “Sensitive But Unclassified” Information
The government’s use of the problematic “sensitive but unclassified” (SBU) designation to restrict access to information that does not warrant classification is coming under new scrutiny.
“Federal agencies do not use uniform definitions of SBU information or have consistent policies for safeguarding or releasing it,” a new study from the Congressional Research Service (CRS) observed.
“This lack of uniformity and consistency raises issues about how to identify SBU information, especially scientific and technical information; how to keep it from those who would use it malevolently, while allowing access for those who need to use it; and how to develop uniform nondisclosure policies and penalties.”
The 82-page CRS report presents a comprehensive treatment of this vexing subject. It surveys the origins of government SBU practices; explores “contentious issues” involving SBU; and considers recommendations to improve SBU policy.
CRS does not permit direct public access to its publications, but a copy was obtained by Secrecy News.
See “‘Sensitive But Unclassified’ Information and Other Controls: Policy and Options for Scientific and Technical Information,” dated February 15, 2006 (published March 14, 2006).
The Government Accountability Office yesterday released a report on SBU policies at the Departments of Energy and Defense to coincide with a House Government Reform Subcommittee hearing. See “Managing Sensitive Information: Departments of Energy and Defense Policies and Oversight Could Be Improved,” Report No. GAO-06-369, March 2006.
The National Security Archive conducted its own survey of SBU policies at federal agencies and released a report entitled “Pseudo-Secrets: A Freedom of Information Audit of the U.S. Government’s Policies on Sensitive Unclassified Information.”
To encourage greater adoption of generic drugs in clinical practice the FDA should implement a dedicated regulatory pathway for non-manufacturers to seek approval of new indications for repurposed generic drugs.
The increasing frequency of extreme weather events, which caused over $200 billion in global economic losses in 2023, is disrupting global supply chains and exacerbating migration pressures, particularly for the U.S. Investing in climate resilience abroad offers a significant opportunity for U.S. businesses in technology, engineering, and infrastructure, while also supporting job creation at home.
Early-career and out-of-state teachers tend to be most heavily concentrated in Alaska’s rural schools, where they face a steep curve in adjusting to a new way of life while learning the ropes of teaching.
By leveraging its substantial purchasing power responsibly, the government can encourage high-quality, inclusive AI solutions that address diverse citizen needs while setting a strong precedent for innovation and accountability.